Sign in

or Register now

MultipleSclerosisCentral.com

See all of our health sites at www.HealthCentral.com
Saturday, November, 21, 2009
  • Font size
  • Bookmark
  • Save
Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

Lisa Emrich's SharePosts

Report Adverse Events Directly to the FDA MedWatch Program

  The FDA Safety Information and Adverse Event Reporting Program   “Your FDA gateway for finding clinically important safety information and reporting serious problems with human medical products.”   Consumers and the Food and Drug Administration (FDA)   Consumers play an important public health role by... Read moreChevron

MS Central Question of the Week

Last week, the FDA held a 2-day hearing on the subject of Social Media, the Internet, and Pharmaceutical Advertising (please read post and comment ).  I attended an event which HealthCentral hosted Thursday evening and afterwards had dinner with a small group of folks.   At one point during the conversation, Jeremy Shane asked, "but... Read moreChevron

FDA, Social Media, and Pharmaceutical Advertising

I’m looking for your thoughts and opinions on a matter which may directly impact us as patients and the manner in which we get information.  This Thursday and Friday (November 12-13, 2009), the Food and Drug Administration (FDA) is holding a public hearing “on how pharmaceutical companies use the web and social-media tools to... Read moreChevron

MS Can Take a Hike!

Those are words I said in an unguarded moment sometime last month when I was visiting my primary doctor because of bronchitis.  I was coughing up a storm, could hardly breathe due to the spasms caused by the irritation in my lungs, and was hacking up the grossest globs of opaque gunk you’ve ever seen come out of a lung.   In... Read moreChevron

Tysabri in the News with 24th Case of PML

Tysabri has been in the news again this week.  Last Friday the European Medicines Agency (EMEA) announced that they would review the benefits and risks for Tysabri.   The Committee started a review of the benefits and risks of Tysabri, in view of reports of 23 cases of progressive multifocal leukoencephalopathy (PML) worldwide since... Read moreChevron

  • Font size
  • Bookmark
  • Save
  • Report abuse

Ask a Question

Get answers from our experts and community members.

View all questions (1017) >